1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)Hypersensitivity, Immediate, Pathological Conditions, Signs and Symptoms, Respiratory Hypersensitivity, Respiratory Sounds, Signs and Symptoms, Signs and Symptoms, Respiratory, Wheezing, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorderEnrolling by invitationPhase 32026-08-13NCT06191315